Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Receivables (2020 - 2026)

NeuroPace has reported Receivables over the past 7 years, most recently at $14.8 million for Q1 2026.

  • For Q1 2026, Receivables rose 14688.0% year-over-year to $14.8 million; the TTM value through Mar 2026 reached $14.8 million, up 14688.0%, while the annual FY2025 figure was $14.7 million, 14.24% up from the prior year.
  • Receivables for Q1 2026 was $14.8 million at NeuroPace, up from $14.7 million in the prior quarter.
  • Over five years, Receivables peaked at $14.9 million in Q3 2025 and troughed at $100000.0 in Q1 2025.
  • A 5-year average of $10.7 million and a median of $11.3 million in 2023 define the central range for Receivables.
  • Biggest five-year swings in Receivables: crashed 99.14% in 2025 and later soared 14688.0% in 2026.
  • Year by year, Receivables stood at $7.5 million in 2022, then soared by 64.39% to $12.3 million in 2023, then grew by 4.48% to $12.9 million in 2024, then increased by 14.24% to $14.7 million in 2025, then increased by 0.73% to $14.8 million in 2026.
  • Business Quant data shows Receivables for NPCE at $14.8 million in Q1 2026, $14.7 million in Q4 2025, and $14.9 million in Q3 2025.